Register Here

2017 Agenda

  • 8:00 am

  • Networking Room Opens

    • Registration Hosted by:

    • Badge and Material Pick-Up
    • Breakfast
    • Meet the Exhibitors

  • DPharm Part I: Patients, Innovation and Disruption

  • 8:45 am

  • Patient Keynote Speaker

    By age 16, our keynote speaker had been through more challenges than what most experience in a lifetime. Nevertheless, her reaction was not one of despair. Her steadfast conviction and perseverance led to achievements far beyond what many could have ever imagined. Instead of viewing her experiences as a tragedy, she began sharing her story with the masses, inspiring them with her universal message about the power and the strength of the human spirit.

    Named one of GLAMOUR magazine’s Top 10 College Women of 2012, she graduated with high honors from Princeton University, receiving the Allen Macey Dulles Award for the graduating senior who best represents Princeton’s motto: “Princeton in the Nation’s Service and in the Service of All Nations.” She has appeared on Dateline, Good Morning America, ABC’s World News Tonight, MTV, and Telemundo, among many others. She has also written for and been featured in a variety of online and print publications, including Dr. Oz: The Good Life, Woman’s Day, The New York Times, New York Daily News, AOL Health,, The Associated Press, The Wall Street Journal, Business Insider, National Geographic Explorer for Kids, GLAMOUR, Cosmopolitan, Huffington Post, and USTA Magazine. Her amazing story of courage and determination has been what Extra called “an inspirational tale of survival that gives us all hope.”

    Jessica Melore
    Patient Advocate
  • 9:20 am

  • Co-Chair's Opening Remarks

    Andreas Koester, MD, PhD

    VP, Innovation, R&D Operations, Janssen

    Bray Patrick-Lake, MFS

    Director of Stakeholder Engagement, Duke Clinical Research Institute

  • 9:30 am

  • R&D Executives on What They Want to Disrupt

    This is a quick fire session to learn what some of the most influential companies are prioritizing in innovation for the advancement of clinical trials. Audience members will be invited to share ambitious projects they want to stretch. Our goal at DPharm is to widely communicate an understanding of our different goals so that we can help each other.


    Valerie Bowling New
    Valerie Bowling

    Executive Director, DPharm


    Rob DiCicco
    Rob Dicicco, PharmD

    VP, Clinical Innovation and Digital Platforms, GSK

    Hassan Kadhim

    Business Consultant, IS BP R&DM, Boehringer Ingelheim

    Ülo Palm, MD, PhD

    SVP, Drug Development Operations, Allergan

    Dan Rothman
    Dan Rothman
    Chief Information Officer, Roivant Sciences

    Michelle Shogren
    Portfolio and Operations Innovation Manager, Global Clinical Development, Bayer

    Jennifer Wulff, MBA

    Director, Clinical Innovation, Pfizer, Inc

  • 10:00 am

  • Bootstrapping Innovation: How Eli Lilly and Pfizer Make Innovation a Reality in Clinical Trials

    We are frequently requested to include a session at DPharm that walks attendees through the process of how pharma is accelerating the adoption of new ideas and technologies. In this session, Eli Lilly and Pfizer share and compare some of their approaches and processes to accelerate the adoption of new technologies and ideas, as well as discussing challenges and obstacles.

    Craig Lipset, MBA

    Head of Clinical Innovation, Pfizer, Inc

    Barry Crist

    Lead Investigator, Lilly Clinical Open Innovation Team, Eli Lilly & Company

  • 10:30 am

  • ADAPTABLE: Aspirin Study – A New System to Do Clinical Studies

    ADAPTABLE (Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-Term Effectiveness) is a three-year pragmatic clinical trial that will compare the effectiveness of two different daily doses of aspirin widely used to prevent heart attacks and strokes in individuals living with heart disease. In this trial, patients are being reached out to electronically via email and via a patient portal. What makes this especially interesting is that patients are actively engaged in the design, conduct, oversight, and dissemination.

    Adrian Hernandez, MD

    Co-Principal Investigator, ADAPTABLE, the Aspirin Study, PCORnet

  • 11:00 am

  • Morning Networking Session

    • Ask the Patient
    • Partnering tables
    • Technology demos
    • Meet the exhibitors
    • Coffee/tea & chocolates by Boston’s oldest chocolatier
    • Patient empathy teachers with therapy dogs
    • Art therapy
  • 11:45 am

  • Myth Buster #1: New Technology can Eliminate Non-enrolling Sites in Clinical Trials

    Myth Busted: What is this reality?

    • What does being good at site selection look like in this environment?
    • Are we proactive enough with independent objective ways to validate which sites to use?
    • How are we using site selection tools?
    • What is the best fit for situation?

    Suzanne Caruso
    Suzanne Caruso

    VP, Clinical Solutions, WIRB-Copernicus Group (WCG)

    Laura Galuchie

    TransCelerate Program Lead, Merck

    Stephanie Petrone
    Navigate Clinical Consulting (Formerly Exec Director, Novartis Oncology), Novartis

  • 12:10 pm

  • Returning Results and Value in Research with Project Baseline

    Adrian Hernandez, MD

    Co-Principal Investigator, ADAPTABLE, the Aspirin Study, PCORnet

    Bray Patrick-Lake, MFS

    Director of Stakeholder Engagement, Duke Clinical Research Institute

  • 12:40 pm

  • Disrupting Clinical as a Care Option

    Kent Thoelke
    Kent Thoelke

    EVP, Scientific & Medical Affairs, Parallel 6, a PRA Health Sciences Company

    David Turner
    David Turner Jr, MS, CISA

    CEOParallel 6, a PRA Health Sciences Company

  • 1:00 pm

  • Lunch and Networking

  • DPharm Part II: New Ideas and Progress – you will be surprised who is leading some of the advances!

  • 2:00 pm
    - 3:00 pm

  • Break Out Choices

    • Patient Disrupters: The Ultimate Partner!

      2:00 pm- 3:00 pm

      Hear how these patients and providers are driving the research. A look at the reality of our future in clinical research.

      2:00 pm
      Reducing the Burden of Type 1 Diabetes through a Model of Democratized R&D

      Dana Lewis

      Creator, Do-It-Yourself Pancreas System and Founder, OpenAPS


      2:20 pm
      Patient-Initiated Research & Crowdsourced Science Meet Academic Medicine: The Story of SCAD Research

      Sharonne Hayes, MD

      Principal Investigator, Mayo Clinic Spontaneous Coronary Artery Dissection (SCAD) Research Program, Mayo Clinic


      2:40 pm
      A Cancer Survivor Driving  System Changes in Research Protocols and Regulatory Approval Process for Lethal Diseases

      John-Peter Bradford, PhD

      CEO, Life-Saving Therapies Network

    • Learn How a Disruptive Model of Patient and Clinician Made Health Devices can Impact the Design of Clinical Trials

      2:00 pm- 2:15 pm

      Meet the medical maker and CEO of MakerHealth who will introduce how her company is giving patients and clinicians tools to build personalized medical devices to generate their own clinical data. By connecting these pioneering health maker patients and clinicians the DIY devices are replicated across the network using digital fabrication tools and training from the MakerHealth Spaces. Learn how this disruptive model of patient and clinician made health devices can impact the design of clinical trials.

      Anna Young
      Anna Young

      Co-founder and CEOMakerHealth

  • 3:00 pm

  • Turbo Tax for Clinical Trials: A Case Study

    In this session, Jae will give us a brief overview on how goBalto has advanced study start up and provide new data on benchmarking performance.

    Jae Chung, MBA

    President & Founding Visionary, goBalto

    Lorena Gomez

    Director of Global Study Startup, Allergan

  • 3:15 pm
    - 4:35 pm

  • Choice of Two Tracks

    • Track One: Where are They Now?

      This track highlights companies who have shared their innovation at a previous DPharm conference, but have exciting advances to report on.

      Track Chair:

      Ülo Palm, MD, PhD
      SVP, Drug Development Operations

      Presenting Companies:

      3:20 pm
      Using Artificial Intelligence for Continuous Patient Monitoring

      Adam Hanina, MBA


      3:30 pm
      “Site-less Clinical Trials: #patients@thecenter”

      Science 37
      Noah Craft, MD, PhD, DTMH
      Co-founder and CEO

      3:40 pm
      Transforming Patient Recruitment at the Enterprise Level with iConnect 2.0

      TrialX Inc
      Sharib Khan, MD, MPH

      Co-founder and CEO

      3:50 pm
      Accelerating Innovation with Unified Clinical

      Veeva Systems
      Henry Levy

      Chief Strategy Officer

      4:00 pm
      The Paperless Clinical Trial: Mysterious Myths and Tantalizing Truths

      Target Health
      Jules Mitchel, PhD


      4:10 pm
      Providing New Alternatives and Efficiencies to Clinical Studies with an Innovative and Simplified Clinical Supply Process

      Tom GottschalkRxSolutions
      Tom Gottschalk

      Executive Director, Business Development

      4:20 pm
      Achieving a Paperless Ecosystem in Clinical Research

      Medpoint Digital
      Bill Cooney, MBA

      President and CEO

      4:25 pm
      How the Spaulding Hand Held ECG Device Disrupted the Market

      randol spaulding

      Spaulding Clinical Research (DPharm Idol winner 2012)
      Randy Spaulding
      CEO and Founder


      4:30 pm
      The Paperless Clinical Trial: Where is the Industry Now?

      Nicholas SlackePharmaSolutions / WIRB-Copernicus Group (WCG)
      Nicholas Slack, MBE 
      President / Chief Growth Officer

    • Track Two: Innovative Sources and Solutions

      This track features companies who are new to presenting at DPharm and have interesting technologies and services to help with clinical trial management, matching, acceleration and recruitment.

      Track Chair:

      Jane Rhodes, PhD
      Senior Director, New Initiatives
      Biogen Idec

      Presenting Companies:

      3:20 pm
      Tales from Entrepreneurship – Innovation Doesn’t Just Come from Big Ideas

      Shawn Blackburn



      3:35 pm
      Once Lost Now Found: Discovering the Last Mile Solution to Accessing Patients in Healthcare

      Elligo Health Research
      Deirdre BeVard

      Chief Operating Officer


      3:45 pm
      Airbnb for Clinical Trials: a Network of Tech-enabled Trial Sites to Accelerate Trial Timelines and Enhance the Patient Experience

      Ben LiuTrialspark
      Benjamine Liu

      CEO and Founder


      3:55 pm
      Risk Free Patient Recruitment

      Ivor ClarkeSubjectWell
      Ivor Clarke



      4:00 pm
      GRETEL™: A Platform for Management of Digital Biomarkers in Clinical Trials

      Biospective Inc
      Barry Bedell, MD, PhD
      COO and CSO


      4:05 pm
      How a New Portable Drug Refrigeration and Monitoring System Lowers Costs for at-Home Clinical Trials

      ASD Healthcare
      Chris Flori

      VP, Business Innovation


      4:10 pm
      What is Immediate Clinical Trial Data, and What Could it Mean?

      Cmed Group
      David Connelly, PhD


      4:15 pm
      Pharma Sitting on a Data Gold Mine: An AI Approach to Maximize Pipeline Value

      Pierre-Alexandre Fournier
      CEO and Co-Founder


      4:20 pm
      Cracking the Case: Solutions for Study Delays

      Jill JohnstonWIRB-Copernicus Group (WCG)
      Jill Johnston
      President of WCG Clinical Services Organization


      4:25 pm
      Leveraging the Digitome in Direct to Patient Trials

      Michelle LongmireMedable Inc
      Michelle Longmire, MD
      CEO and Co-founder

  • 4:35 pm

  • Afternoon Networking Session

    • Ask the Patient
    • Partnering tables
    • Technology demos
    • Meet the exhibitors
    • Coffee/tea & chocolates by Boston’s oldest chocolatier
    • Patient empathy teachers with therapy dogs
    • Art therapy
  • 5:05 pm

  • DPharm Idol 2017

    DPharm Idol is the concluding session of day one. In a live-show format, a select group of innovators present what they believe to be a disruptive service or technology that could be a changing force for clinical trials. Each company provides a quick-fire session followed by questions from the DPharm Idol judges. The exchange of Q&A is so helpful to see what you should either be asking or communicating for your own trials.

    Who will be the DPharm Idol 2017 winner? Florence Healthcare, our DPharm Idol 2016 winner, will tell us where they are a year later and kick off DPharm Idol 2017.

    DPharm Idol 2016 Winner Kick Off:

    Ryan Jones, MBA

    CEO, Florence Healthcare


    Presenting Companies

    Outcome Health
    Don Butler

    SVP, Clinical Research Solutions

    Deep6 AI
    Wout Brusselaers

    CEO and Co-founder

    eClinical Solutions
    Sam Anwar

    VP, Engineering

    Zikria Syed

    Patrick-KeenanPrevail InfoWorks
    Patrick Keenan

    Chief Strategist

    Chris EconomosPhysIQ
    Chris Economos, MBA
    VP, Business Development


    DPharm Idol Judges

    Esther Dyson

    Executive Founder, Way to Wellville

    Laura Galuchie

    TransCelerate Program Lead, Merck


    Christian Gossens, PhD, MBA
    Global Head Early Development Workflows, pRED Informatics, Roche Pharmaceutical Research and Early Development (pRED)

    Hassan Kadhim
    Business Consultant, IS BP R&DM, Boehringer Ingelheim

    Andreas Koester, MD, PhD

    VP, Innovation, R&D Operations, Janssen


    Sarah Krüg
    Executive Director / President, Cancer 101 / Society of Participatory Medicine

    Jacob LaPorte
    Jacob LaPorte, PhD

    Head of Digital Development, Novartis

    Craig Lipset, MBA

    Head of Clinical Innovation, Pfizer, Inc

    Ülo Palm, MD, PhD

    SVP, Drug Development Operations, Allergan

    Chandra Ramanathan
    Chandra Ramanathan, PhD, MBA

    Head, East Coast Innovation Center, Bayer, US

    Jane Rhodes, PhD

    Senior Director, New Initiatives, Biogen Idec

    Dan Rothman


    Dan Rothman
    Chief Information Officer, Roivant Sciences

    Alicia Staley
    Patient Advocate

  • 6:00 pm
    - 7:30 pm

  • DPharm Annual Reception

2017 Agenda

  • 8:00 am

  • Networking Room Opens

    Breakfast and Networking

  • DPharm Part III: The Next Generation of Ideas

  • 8:25 am

  • Co-Chair's Address and DPharm Idol 2017 Winner Announced

    Andreas Koester, MD, PhD

    VP, Innovation, R&D Operations, Janssen

    Bray Patrick-Lake, MFS

    Director of Stakeholder Engagement, Duke Clinical Research Institute

  • 8:40 am

  • Blockchain for Drug Development: An Historic Opportunity!

    Pfizer is making advances in working with blockchain and has been one of the first companies to deliver prototype applications on the chain early this year. In this session, learn from an industry insider how blockchain can speed up the drug development process and change the business model of clinical development. Hear why it is imperative to embrace blockchain. More specifically:

    • The basics on how blockchain works and what the key advantages are
    • Key benefits to empowering patients with control over their data
    • The compliance implications of unalterable historic audit trails
    • How in-house proof of concept development fosters innovation and new technology adoption
    • The implications of rich and abundant patient data for the drug development process

    Sascha Mundstein, PhD, MBA

    Mobile and Digital COE, Technology Evangelist, Pfizer, Inc

  • 9:20 am
    - 9:45 am

  • Two Track Choices

    • Track One: Aligning Incentives to Share Clinical Data

      9:25 am

      Dr Isaac (Zak) Kohane reports on the outcome of The SPRINT Challenge, a practical example and “poster child” of data sharing in today’s environment.

      • How the challenge / contest was set up around the question, “Why are we not sharing data from clinical trials?”
      • What did the trialists say about why they would or would not share data?
      • What was the patients’ perspective?
      • Did having more people reviewing the data improve its quality and usefulness?
      • What did we learn about aligning incentives to share clinical data?
      • How can we create a proper framework for sharing data, which currently doesn’t exist?
      • How can we promote opportunities to democratize access to data for new analyses that can go beyond a trial’s primary outcome findings?

      Isaac (Zak) Kohane, MD, PhD

      Chair of the Department of Biomedical Informatics, Harvard Medical School

    • Track Two: Wireless Remote Monitoring – Next Frontier for Patients

      9:25 am

      MIT Professor, Dina Katabi, joins us for a chat about in-home non-intrusive patient monitoring and provides a demo of technology that uses ambient radio signals to monitor a patient’s gait, falls, breathing, heart rate and even sleep, all without putting any sensor on the patient’s body. Find out how they have used the technology to redefine clinical endpoints and pushed clinical trials to the home.

      Dina Katabi
      MacArthur Fellow, Andrew & Erna Viterbi ProfessorMIT, and Director of MIT Center for Wireless Networks and Mobile Computing

  • 9:45 am

  • The Today Show @DPharm

    Topics and Guests:

    Focus on the Goal and Not the Role

    Esther Dyson

    Executive Founder, Way to Wellville

    The Alexa Challenge, Voice & Other Emerging Technologies for Clinical Trials

    Sara Holoubek, MBA

    CEO, Luminary Labs

    Simplifying the Research Journey for Patients and Sites

    E.B. McLindon

    VP, Healthcare Alliances, ICON

  • 10:50 am

  • Morning Networking Session

    • Ask the Patient
    • Partnering tables
    • Technology demos
    • Meet the exhibitors
    • Coffee/tea & chocolates by Boston’s oldest chocolatier, etc
    • Patient empathy teachers with therapy dogs
    • Art therapy
  • 11:35 am

  • Engaging Patients by Giving Them What they Want…their Data!

    Introduction by:

    Elise Felicione
    Elise Felicione, MPH, MBA

    Senior Director, R&D Operations Innovation, Janssen Pharmaceutical Companies of Johnson & Johnson


    Megan McBride, MPH

    Associate Director, R&D Operations Innovation, Janssen Pharmaceutical Companies of Johnson & Johnson


    Carolyn Brehm
    Carolyn Brehm
    Associate Director, Digital Clinical Trials, Global Clinical Operations, Bristol-Myers Squibb

    Andreas Koester, MD, PhD

    VP, Innovation, R&D Operations, Janssen

    David Leventhal
    David Leventhal, MBA 

    Director of Clinical Innovation, Pfizer, Inc

  • 12:00 pm

  • Building a Strategic Patients Community Beyond Clinical Trials

    If you want to give patients data back, you need a community. In this session, you will learn how this works.

    Thomas Klein

    Founder and CEO, Be the Partner

  • 12:15 pm

  • Clinical Trial Matching - Next Generation

    Pablo Graiver

    CEO and Founder, Antidote

    Ed Godber

    Entrepreneur-in-Residence, Antidote
  • 12:30 pm
    - 1:15 pm

  • Three Track Choices

    • Track One: Digital Therapeutics

      12:35 pm

      Digital Therapeutics, Gaming as a Therapy: Who Is Doing What and Where Are They Now?

      Insights on:

      • Digital therapeutics for enhanced clinical outcomes
      • How to use digital as part of the treatment
      • How to incorporate digital therapeutics in clinical trials
      • When does it make sense to use digital therapeutics?

      Eddie Martucci, PhD

      CEO, Akili Interactive Labs

      Jason Kahn, PhD

      Co-Founder and CSO
      Neuromotion Labs

    • Track Two: Customer Centric and the Digital Patient Journey

      12:35 pm- 12:55 pm

      Myth Buster #2 –
      Flip the Clinic

      Myth: Innovation always relies on technology.

      Myth Busted: No, it does not. It happened.

      Whitney Bowman-Zatzkin
      Whitney Bowman-Zatzkin, MPA, MSR

      Director, Flip the Clinic

    • Creating a Digital Journey for the Patient

      12:55 pm- 1:15 pm

      “Fit for Patient”

      Paulo Moreira

      VP, Global Clinical Operations, External Innovation, EMD Serono

      Martin Collyer
      Martin Collyer

      COO, Bioclinica

    • Track Three: New Innovation from Old Science and Artificial Intelligence

      12:35 pm- 12:55 pm

      The Next Generation of Clinical Trials: Lessons from the Hurdles of the Microbiome

      Zain Kassam, MD, MPH, FRCPC

      CMO, OpenBiome

    • How Artificial Intelligence will Impact Healthcare of the Future and in Particular Clinical Trials

      12:55 pm- 1:15 pm

      What are the capabilities for clinical trials?

      Zen Chu, MBA

      Faculty Director, MIT Healthcare Ventures and Hacking Medicine

  • 1:15 pm
    - 2:15 pm

  • Lunch

  • 1:30 pm
    - 2:15 pm

  • Optional Lunch Session: What Would it Take to Really Make Clinical Research a Care Option

    Grab your lunch and join us in this session, where you have the opportunity to attend one of the most disruptive movements in the clinical research ecosystem. Last year at DPharm, this was a closed door meeting and we are delighted to open it to the entire DPharm community. After attendees get their lunch in the networking room, go to the session in the CRAACO room.


    John McConnell, MD

    CEO Emeritus, Wake Forest Baptist Medical Center / Executive Director & Chair, WF Healthcare Ventures


    Jeremy Sohn

    VP, Global Head of Digital Business Development, Novartis

    Kenneth Mandl, MD

    Professor of Biomedical Informatics and Pediatrics, Harvard Medical School and Director Computational Health Informatics Program, Boston Children’s Hospital

    Noah Craft, MD, PhD

    Co-founder and CEO, Science 37

  • DPharm Part IV: The concluding portion of DPharm is composed of a series of brief, but impactful sessions devoted to progress in innovation from all stakeholders.

  • 2:15 pm

  • What Cognitive Computing can do when Applied to Big Data in Clinical Trials

    Jeff Beeler

    Solutions Executive, IBM Watson Health

    Kim Kenna
    Kimberly Kenna

    Development Architect, Watson for Clinical Trial Matching, IBM

  • 2:30 pm

  • Turning Opportunity into Reality: Real Data and Practical Guidance for Incorporating Mobile Technology in Clinical Trials

    This panel discussion brings together key industry voices, who are collaborating on recommendations for the use of mobile technology in clinical trials. The insights come from the work of CTTI’s Mobile Clinical Trials Program. They share the latest findings and draft recommendations after the point of informed consent on the use of mobile technologies in regulated clinical trials. This will include the patient perspective, tips for dealing with large volumes of data, engaging with FDA during trial design, execution, and monitoring. Join us for an evidence-based and thought-provoking discussion of real data and practical guidance to actualize these opportunities.


    Komathi Stem

    Founder, monARC BioNetworks


    Ray Dorsey, MD, MBA

    David M. Levy Professor of Neurology and Director of the CHET, University of Rochester

    Cindy Geoghegan

    Principal, Patient and Partners LLC

    Gary Grabow new
    Gary Grabow, Esq

    Assistant General Counsel, Genentech

  • 3:10 pm

  • Where Are They Now: Eli Lilly’s Hero’s Journey Project

    Kelly McKee

    Advisor, Clinical Innovation, Eli Lilly & Company

  • 3:25 pm

  • Investing in Digital Biomarkers

    • What do we need to know?
    • What is the reality of digital biomarkers in measuring disease?
    • What is the pathway?

    Led by:

    Joseph Kim, MBA

    Senior Advisor, Clinical Innovation, Eli Lilly & Company

    Sohini Chowdhury
    Deputy CEO, The Michael J. Fox Foundation 
  • 4:00 pm

  • TransCelerate Report on Progress and Next Steps to Drive Innovation in Clinical Research

    In this brief report, hear about the strategic priorities of TransCelerate in a discussion on selected ongoing and recently initiated projects.

    Andreas Koester, MD, PhD

    VP, Innovation, R&D Operations, Janssen

    Craig Lipset, MBA

    Head of Clinical Innovation, Pfizer, Inc

    Ülo Palm, MD, PhD

    SVP, Drug Development Operations, Allergan

  • 4:30 pm

  • Myth Buster #3: Data Donation App

    Myth Busted: It’s happening.

    Munther Baara

    Senior Director, Clinical Paradigm, Pfizer, Inc

  • 5:00 pm

  • DPharm 2017 Concludes

2017 Agenda

Wednesday, September 6, 2017

  • Full Day Conference on Mobile in Clinical Trials

    This full day conference scheduled the day before DPharm goes into detail on:

    • real-time implementation of mobile solutions
    • trials driving efficiency
    • how to scale up
    • perceived barriers and how to overcome them
    • moving past the hype of mhealth and producing evidence
    • optimizing the true value of mobile data
    • Mobile 2.0, wearable, sensors, apps and mobile devices

    Go to Mobile in Clinical Trials Conference>>